| Genetics of diabetic retinopathy, a leading cause of irreversible blindness in the industrialized world AD Bhatwadekar, A Shughoury, A Belamkar, TA Ciulla Genes 12 (8), 1200, 2021 | 43 | 2021 |
| Retinal oximetry in glaucoma: investigations and findings reviewed A Shughoury, S Mathew, J Arciero, P Wurster, S Adjei, T Ciulla, B Siesky, ... Acta Ophthalmologica 98 (6), 559-571, 2020 | 19 | 2020 |
| The complement system: a novel therapeutic target for age-related macular degeneration A Shughoury, DD Sevgi, TA Ciulla Expert Opinion on Pharmacotherapy 24 (17), 1887-1899, 2023 | 17 | 2023 |
| Molecular genetic mechanisms in age-related macular degeneration A Shughoury, DD Sevgi, TA Ciulla Genes 13 (7), 1233, 2022 | 15 | 2022 |
| The evolving therapeutic landscape of diabetic retinopathy A Shughoury, A Bhatwadekar, D Jusufbegovic, A Hajrasouliha, TA Ciulla Expert Opinion on Biological Therapy 23 (10), 969-985, 2023 | 3 | 2023 |
| Genes and gene therapy in inherited retinal disease A Shughoury, TA Ciulla, B Bakall, ME Pennesi, S Kiss, ET Cunningham Jr International ophthalmology clinics 61 (4), 3-45, 2021 | 3 | 2021 |
| Rhegmatogenous retinal detachment in syphilitic uveitis: a case series and comprehensive review of the literature A Shughoury, EW Carr, RS Moorthy Ocular Immunology and Inflammation, 1-12, 2023 | 1 | 2023 |
| The Complement System: A New Therapeutic Target A Shughoury, T Ciulla Retina Today 2023 (May/June), 2023 | | 2023 |
| A Basic Primer on Gene Therapy A Shughoury, T Ciulla Retinal Physician 2023 (March), 27-31, 2023 | | 2023 |
| OCT Biomarkers in Uveitic Macular Edema A Shughoury, T Ciulla Retina Today 2022 (July/August), 2022 | | 2022 |
